The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Streptococcus agalactiae

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Streptococcus agalactiae


High impact information on Streptococcus agalactiae


Chemical compound and disease context of Streptococcus agalactiae


Biological context of Streptococcus agalactiae


Anatomical context of Streptococcus agalactiae

  • Many group B Streptococcus agalactiae strains and other pathogenic streptococci express a cell-associated peptidase that inactivates C5a (C5a-ase), the major neutrophil chemoattractant produced by activation of the complement cascade [20].
  • The type-specific capsular polysaccharide antigen of Streptococcus agalactiae has in previous experimental studies been considered a significant antiphagocytic factor, whereas the lipoteichoic acid moiety has been suggested to be a factor in adherence to human fetal cell lines [21].
  • The role of macrophages in experimental arthritis induced by Streptococcus agalactiae sonicate: actions of macrophage colony-stimulating factor (CSF-1) and other macrophage-modulating agents [22].

Gene context of Streptococcus agalactiae


Analytical, diagnostic and therapeutic context of Streptococcus agalactiae


  1. L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement. Lynch, N.J., Roscher, S., Hartung, T., Morath, S., Matsushita, M., Maennel, D.N., Kuraya, M., Fujita, T., Schwaeble, W.J. J. Immunol. (2004) [Pubmed]
  2. In vitro antimicrobial activity of aztreonam alone and in combination against bacterial isolates from pediatric patients. Stutman, H.R., Welch, D.F., Scribner, R.K., Marks, M.I. Antimicrob. Agents Chemother. (1984) [Pubmed]
  3. In vitro activity of U-57930E, a new clindamycin analog, against aerobic gram-positive bacteria. Ahonkhai, V.I., Cherubin, C.E., Shulman, M.A., Jhagroo, M., Bancroft, U. Antimicrob. Agents Chemother. (1982) [Pubmed]
  4. Evaluation of the Rapid Mastitis Test for identification of Staphylococcus aureus and Streptococcus agalactiae isolated from bovine mammary glands. Watts, J.L., Owens, W.E. J. Clin. Microbiol. (1988) [Pubmed]
  5. Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelines. Gerlach, E.H., Jones, R.N., Allen, S.D., Koontz, F.P., Murray, P.R., Pfaller, M.A., Washington, J.A., Erwin, M.E. Diagn. Microbiol. Infect. Dis. (1992) [Pubmed]
  6. Glutathione synthesis in Streptococcus agalactiae. One protein accounts for gamma-glutamylcysteine synthetase and glutathione synthetase activities. Janowiak, B.E., Griffith, O.W. J. Biol. Chem. (2005) [Pubmed]
  7. A eukaryotic type serine/threonine kinase and phosphatase in Streptococcus agalactiae reversibly phosphorylate an inorganic pyrophosphatase and affect growth, cell segregation, and virulence. Rajagopal, L., Clancy, A., Rubens, C.E. J. Biol. Chem. (2003) [Pubmed]
  8. Regulation of purine biosynthesis by a eukaryotic-type kinase in Streptococcus agalactiae. Rajagopal, L., Vo, A., Silvestroni, A., Rubens, C.E. Mol. Microbiol. (2005) [Pubmed]
  9. Erythromycin resistance and genetic elements carrying macrolide efflux genes in Streptococcus agalactiae. Marimón, J.M., Valiente, A., Ercibengoa, M., García-Arenzana, J.M., Pérez-Trallero, E. Antimicrob. Agents Chemother. (2005) [Pubmed]
  10. New lnu(C) gene conferring resistance to lincomycin by nucleotidylation in Streptococcus agalactiae UCN36. Achard, A., Villers, C., Pichereau, V., Leclercq, R. Antimicrob. Agents Chemother. (2005) [Pubmed]
  11. High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Hsueh, P.R., Teng, L.J., Lee, L.N., Ho, S.W., Yang, P.C., Luh, K.T. Antimicrob. Agents Chemother. (2001) [Pubmed]
  12. Opsonization of Streptococcus agalactiae of bovine origin by complement and antibodies against group B polysaccharide. Rainard, P., Boulard, C. Infect. Immun. (1992) [Pubmed]
  13. Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae. Betriu, C., Culebras, E., Gómez, M., Rodríguez-Avial, I., Sánchez, B.A., Agreda, M.C., Picazo, J.J. Antimicrob. Agents Chemother. (2003) [Pubmed]
  14. High-level chromosomal gentamicin resistance in Streptococcus agalactiae (group B). Buu-Hoï, A., Le Bouguenec, C., Horaud, T. Antimicrob. Agents Chemother. (1990) [Pubmed]
  15. Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci). von Hunolstein, C., D'Ascenzi, S., Wagner, B., Jelínková, J., Alfarone, G., Recchia, S., Wagner, M., Orefici, G. Infect. Immun. (1993) [Pubmed]
  16. Cloning of the glutamine synthetase gene from group B streptococci. Suvorov, A.N., Flores, A.E., Ferrieri, P. Infect. Immun. (1997) [Pubmed]
  17. Characterization of Enterococcus faecalis alkaline phosphatase and use in identifying Streptococcus agalactiae secreted proteins. Lee, M.H., Nittayajarn, A., Ross, R.P., Rothschild, C.B., Parsonage, D., Claiborne, A., Rubens, C.E. J. Bacteriol. (1999) [Pubmed]
  18. The TraA relaxase autoregulates the putative type IV secretion-like system encoded by the broad-host-range Streptococcus agalactiae plasmid pIP501. Kurenbach, B., Kopeć, J., Mägdefrau, M., Andreas, K., Keller, W., Bohn, C., Abajy, M.Y., Grohmann, E. Microbiology (Reading, Engl.) (2006) [Pubmed]
  19. Binding of bovine fibronectin to mastitis-causing Streptococcus agalactiae induces adherence to solid substrate but not phagocytosis by polymorphonuclear cells. Rainard, P. Microb. Pathog. (1993) [Pubmed]
  20. Genetic polymorphisms of group B streptococcus scpB alter functional activity of a cell-associated peptidase that inactivates C5a. Bohnsack, J.F., Takahashi, S., Hammitt, L., Miller, D.V., Aly, A.A., Adderson, E.E. Infect. Immun. (2000) [Pubmed]
  21. Sialic acid levels and lag time of growth in chemically defined medium containing 200 mM phosphate among strains of various serotypes of Streptococcus agalactiae. Nagano, Y., Nagano, N., Takahashi, S., Suzuki, A., Okuwaki, Y. J. Clin. Microbiol. (1989) [Pubmed]
  22. The role of macrophages in experimental arthritis induced by Streptococcus agalactiae sonicate: actions of macrophage colony-stimulating factor (CSF-1) and other macrophage-modulating agents. Abd, A.H., Savage, N.W., Halliday, W.J., Hume, D.A. Lymphokine Cytokine Res. (1991) [Pubmed]
  23. Characterization and heterologous expression of the tetL gene and identification of iso-ISS1 elements from Enterococcus faecalis plasmid pJH1. Platteeuw, C., Michiels, F., Joos, H., Seurinck, J., de Vos, W.M. Gene (1995) [Pubmed]
  24. Generation of complement fragment C5a in milk is variable among cows. Rainard, P., Poutrel, B. J. Dairy Sci. (2000) [Pubmed]
  25. Cloning and characterization of a novel macrolide efflux gene, mreA, from Streptococcus agalactiae. Clancy, J., Dib-Hajj, F., Petitpas, J.W., Yuan, W. Antimicrob. Agents Chemother. (1997) [Pubmed]
  26. Investigation of the translation-initiation factor IF2 gene, infB, as a tool to study the population structure of Streptococcus agalactiae. Hedegaard, J., Hauge, M., Fage-Larsen, J., Mortensen, K.K., Kilian, M., Sperling-Petersen, H.U., Poulsen, K. Microbiology (Reading, Engl.) (2000) [Pubmed]
  27. NeuD plays a role in the synthesis of sialic acid in Escherichia coli K1. Daines, D.A., Wright, L.F., Chaffin, D.O., Rubens, C.E., Silver, R.P. FEMS Microbiol. Lett. (2000) [Pubmed]
  28. Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter study. De Mouy, D., Cavallo, J.D., Leclercq, R., Fabre, R. Antimicrob. Agents Chemother. (2001) [Pubmed]
  29. Rapid bioassay for clindamycin alone and in the presence of aminoglycoside antibiotics. Jorgensen, J.H., Lee, J.C. J. Infect. Dis. (1977) [Pubmed]
  30. Activation of the classical pathway of complement by binding of bovine lactoferrin to unencapsulated Streptococcus agalactiae. Rainard, P. Immunology (1993) [Pubmed]
  31. Evaluation of a rapid latex test for direct detection of Streptococcus agalactiae in various obstetrical and gynaecological disorders. Quentin, R., Dubarry, I., Gignier, C., Saulnier, M., Pierre, F., Goudeau, A. Eur. J. Clin. Microbiol. Infect. Dis. (1993) [Pubmed]
  32. Complementary exploration of the action pattern of hyaluronate lyase from Streptococcus agalactiae using capillary electrophoresis, gel-permeation chromatography and viscosimetric measurements. Kühn, A.V., Ozegowski, J.H., Peschel, G., Neubert, R.H. Carbohydr. Res. (2004) [Pubmed]
WikiGenes - Universities